Document is current
Any future updates will be listed below
-
Authors
Chang, Yu-Cheng
Xu, Yichu
Tsai, Ya-Chea
Yu, Ching-Wen
Chang, Chih-Long
Huang, Chuan-Hsiang
Wu, T.-C.
Hung, Chien-Fu
-
Funding
Funding for this research was provided by:
National Cancer Institute (P50CA098252)
National Cancer Institute (R21DE034547)
- License Information
-
More Information
Article History
Received: 12 February 2026
Accepted: 15 June 2026
First Online: 3 July 2026
<!--Emphasis Type='Bold' removed-->Ethical statement
:
: T.C.W. is a co-founder of and has an equity ownership interest in Papivax LLC. Also, he owns Papivax Biotech Inc. stock options and is a member of Papivax Biotech Inc.’s Scientific Advisory Board. Additionally, under a licensing agreement between Papivax Biotech Inc. and the Johns Hopkins University, T.C.W. and CF.H. are entitled to royalties on an invention described in this article. This arrangement has been reviewed and approved by the Johns Hopkins University in accordance with its conflicts of interest policies. Other co-authors declared no conflicts of interest.
: for this study was obtained from Animal Care and Use Committee at Johns Hopkins University (Protocol Number: MO23M84).
